Su-Ying Wu
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 20, 2025
Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix.Yi-Hui Peng, Mu-Chun Li, Wan-Ching Yen
|Nov 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.Hsin-Huei Chang, Lung-Chun Lee, Tsu Hsu
|Aug 02, 2021
Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).Lung-Chun Lee, Yi-Hui Peng, Hsin-Huei Chang
|Jun 24, 2020
Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.Yi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng
|Jan 22, 2020
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.Yi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng
|Nov 14, 2019
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia.Wen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh
Pageof 2
